SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 4.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 47.1. According to RSI analysis, sunpharma is technically weak. 1.0 SUNPHARMA RSI Chart
MACD (?) MACD: -2.89 and Signal Line: -5.86. According to MACD analysis, sunpharma is marginally strong. 7.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is facing resistance at 661 and support level is at 636.74. 6.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sunpharma is in a strong downtrend. Major resistance levels are 643.8161, 662.0521, 733.7093. 0.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.599. 5.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% level. Support is at 632.6571 Resistance levels are 651.425 and 670.1929. 6.5 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 13.9 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 26 which means SUNPHARMA is in a trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 20, 2017
Open Price 642.85
High Price 647.4
Low Price 640.0
Close Price 641.55
Absolute Change -1.9
Percentage Change -0.295%
Weekly Change -1.75%
Monthly Change 2.89%
Yearly Change -19%
52-week high 898.45
52-week low 571.9
Corporate Actions
ExDate Purpose
September 08, 2016 AGM/DIV-RE 1/- PER SHARE
July 14, 2016 BUY BACK
October 21, 2015 AGM/DIV-RS 3 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.593
Confidence in Beta1.8%
Market Capital Rs. 154402.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 8.9
TTM Price-to-Earnings (P/E) Ratio 72.1
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 20 January 2017: Deliverable Quantity:2.94e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 20 January 2017: Daily Volatility:0.2828 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 20 January 2017: PCR_OI:0.556 PCR:0.808 NA SUNPHARMA PCR Chart
Premium (?) 20 January 2017 Premium: -0.05 Futures OI:24182200.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 20 January 2017: Price:641.55 Put with maximum OI:600.0 Call with maximum OI:660.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2017 641.5 24182200.0 4617.0 6733.0 641.55
February 23, 2017 644.0 5848500.0 1296.0 3045.0 641.55
March 30, 2017 646.65 35700.0 29.0 30.0 641.55

Option Chains - NSE

SUNPHARMA Option Zone

Announcements

January 05, 2017 SPress ReleaseSun Pharmaceuticals Industries Limited has informed the Exchange regarding a press release dated January 04, 2017, titled "Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera for Treatment of Dry Eye ".
December 29, 2016 TNews ClarificationThe Exchange has sought clarification from Sun Pharmaceuticals Industries Limited with respect to recent news item captioned "Blast at Sun Pharma unit''. The response from the Company is enclosed.
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 25, 2016 November 10, 2016 TResults/OthersTo transact, interalia, the following business:
August 01, 2016 August 12, 2016 iResultsinteralia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2016.
See all Board Meetings

SUNPHARMA is part of...

Index Weightage
NIFTY 1.88
CNX100 1.6
CNX500 1.34
CNXPHARMA 26.08

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 631.2 Rs. 635.6 Rs. 638.6 Rs. 643 Rs. 646 Rs. 650.4 Rs. 653.4